Etiology and PathogenesisSomatostatin


Journal of Neuro-Oncology 66: 155–166, January 2004. (Laboratory Investigation)


Abstract

Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity

Sara Arena, Federica Barbieri, Stefano Thellung, Paolo Pirani, Alessandro Corsaro, Valentina Villa, Patrizia Dadati, Alessandra Dorcaratto, Gabriella Lapertosa, Jean-Louis Ravetti, Renato Spaziante, Gennaro Schettini and Tullio Florio

Section of Pharmacology, Department of Oncology, Biology and Genetics (S.A., S.T., A,C., V.V., G.S., T.F.),  Section of Neurosurgery DISCAT (A.D.) , Section of Pathology, DICMI (G.L.), Division of Neurosurgery, Department of Neuroscience, Opthalmology and Genetics, University of Genova (R.S.); Pharmacology and Neurosciences, National Institute for Cancer Research (IST), Genova (F.B., P.P., G.S., T.F.); Section of Pathology, San Martino Hospital, Genova, Italy (P.D., J.-L.R.)

Somatostatin receptors (SSTRs) have been detected in many normal and malignant tissues. 
This wide expression has been used for diagnostic, prognostic and therapeutic purposes. 
Five SSTR subtypes (SSTR 1–5) have been identified whose activation is responsible for the signal transduction through many different intracellular pathways.
In the present study the expression of SSTR mRNA was determined by reverse-transcriptase (RT)–PCR in 42 meningiomas. 
About 88% of the tumors analyzed (37/42) were positive for at least one of the five SSTR subtypes displaying a variable pattern of expression of the different SSTR subtypes. 
SSTR1 and SSTR2 were the most frequently mRNA detected (69% and 79% of the sample analyzed, respectively). 
The other subtypes were found in the 43%, 33% and 33% of cases for SSTR3, SSTR4 and SSTR5, respectively. 
In 22, out of 42 patients (52%) three or more SSTRs were detected. 
The expression of the different SSTR subtypes did not correlate with the expression of bcl-2 (apoptosis-associated protein) and MIB-1 (a proliferation marker), assessed by immunohistochemistry in a series of 34 tumor samples, while a correlation between the expression of SSTR3 and p53 was observed (p = 0.08).
To evaluate a possible role of SSTR in the control of human meningioma cell proliferation, seven primary cell specimens we analyzed altogether with in vitro antiproliferative effects of SST may open interesting perspectives for the diagnosis and the therapy of meningiomas.

Key words: meningioma, primary cultures, proliferation, RT–PCR, somatostatin receptors

© 2004 Kluwer Academic Publishers. Printed in the Netherlands.

Source: http://journals.kluweronline.com/article.asp?PIPS=5149479


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP